Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
State/National Statistics: Basic Epidemiology of Skin Cancer Presented by: Chris Johnson, MPH Epidemiologist, Cancer Data Registry of Idaho 4th Annual Conference on Advancing Cancer Care Skin Cancer and Management of Treatment-Related Fatigue April 22-23, 2004 McCleary Center Saint Alphonsus Regional Medical Center Outline • Skin • Skin Cancer – SCC and BCC – Melanoma • Melanoma – Risk Factors – Incidence – Stage – Survival – Mortality – Lifetime Risks – Prevention The Skin • The skin is the body’s largest organ. It protects against heat, sunlight, injury, and infection. It helps regulate body temperature, stores water and fat, and produces vitamin D. • The skin has two main layers: the outer epidermis and the inner dermis. The Skin • The epidermis is mostly made up of flat, scalelike cells called squamous cells. Round cells called basal cells lie under the squamous cells in the epidermis. The lower part of the epidermis also contains melanocytes. • Melanocytes produce melanin, the pigment that gives skin its natural color. When skin is exposed to the sun, melanocytes produce more pigment, causing the skin to tan, or darken. Skin Cancer • Cancer may develop in any of the cell types: – Squamous Cell Carcinoma (SCC) – Basal Cell Carcinoma (BCC) – Melanoma • Skin cancer is the most common form of cancer in the United States. Squamous and Basal Cell Carcinomas • • • The American Cancer Society estimates that approximately 1.3 million new cases of basal cell and squamous cell carcinomas will be detected this year. This is roughly equivalent to the total of all other cancer sites. Death rates from basal cell and squamous cell carcinomas are low. – When detected early, approximately 95% of these carcinomas can be cured. – However, these cancers can cause considerable damage and disfigurement if they are untreated. Basal cell and squamous cell carcinomas are more than 10 times as common as melanoma but account for less morbidity and mortality. – SCC may account for 20% of all deaths from skin cancer. • SCC and BCC are not reportable to CDRI unless regional or distant stage or on a mucous membrane. – There were 11 reportable SCC and BCC skin cases in 2002. • We do not know how many total cases of SCC and BCC there are per year in Idaho, but estimate it to be over 5,000. Melanoma • Melanoma occurs when melanocytes (pigment cells) become malignant. • Most melanocyte cells are in the skin; when melanoma starts in the skin, the disease is called cutaneous melanoma. – Melanoma may also occur in the eye (ocular melanoma or intraocular melanoma). – Rarely, melanoma may arise in the meninges, the digestive tract, lymph nodes, or other areas where melanocytes are found. • Skin melanoma usually begins in a mole. • It can occur on any skin surface. – In men, melanoma is often found on the trunk or the head and neck. – In women, it often develops on the lower legs. Melanoma of the Skin • Melanoma is one of the most common cancers and the most serious type of cancer of the skin. • The American Cancer Society estimates that about 54,200 new cases of malignant melanoma will be diagnosed this year, and 7,600 will die from the disease in the US. • In some parts of the world, especially among Western countries, melanoma incidence is on the rise. – In the United States, melanoma incidence has more than doubled in the past 30 years. • All in situ and invasive melanoma cases are reportable to CDRI. Risk Factors • • • • • • Light skin color, hair color, or eye color. Family history of skin cancer. Personal history of skin cancer. Chronic exposure to the sun. History of sunburns early in life. Certain types of moles, or a large number of moles. • Freckles, which indicate sun sensitivity and sun damage. Ultraviolet Radiation UV Radiation Wavelengths • Ultraviolet radiation (or UV radiation)— Electromagnetic radiation with wavelengths between 100 and 400 nanometers. These rays are emitted from the sun and are not visible. They inflict increasingly more damage upon a recipient as the wavelength decreases. Based on its effects, UV radiation is subdivided into three wavelength ranges named UV-A, UV-B and UV-C: – UV-A covers the wavelength range 320-400 nm. UV-A is not absorbed by the ozone layer and is the least harmful UV radiation (tanning beds). – UV-B covers the wavelength range 280-320 nm. UV-B is more energetic than UV-A, and is partially absorbed by the ozone layer. UV-B rays that are not filtered out cause sunburn and other harmful effects to humans. – UV-C covers the wavelength range 100-280 nm. UV-C is the most dangerous form of UV radiation, but is completely absorbed by the ozone layer. Artificial UV-C (for example emitted by electric discharges) is a threat for certain occupational group, like welders. UV Exposure • More than 90% of skin cancers in the US are attributed to UV-B exposure. – Other causes of skin cancer include arsenic, other chemical exposures. • Human exposure to UV-B depends upon an individual's – location (latitude and altitude) – the duration and timing of outdoor activities (time of day, season of the year = angle of the sun) – and precautionary behavior (use of sunscreen, sunglasses, or protective clothing). UV Exposure Ozone Layer Depletion • Is ozone loss to blame for the melanoma upsurge in the US and Europe? – Unlikely: • UV-B has not yet increased much in the US and Europe • Melanoma takes 10-20 years to develop. There hasn't been enough time for ozone depletion to play a significant role. • Current and future increases in UV radiation exposure due to ozone depletion will exacerbate the trend toward higher incidence of melanoma. UV-B Exposure - Sunburn – 32% of U.S. adults report having had a sunburn in the past year – Parents or caregivers reported that 72% of adolescents aged 11--18 years have had at least one sunburn, and 43% of white children aged <11 years experienced a sunburn in the past year. Sunburn Percentage of Adults who had a Sunburn in Last 12 Months 2003 Idaho BRFSS 100 90 80 Percent 70 60 50 Percent 40 30 20 10 0 Statewide HD 1 HD 2 HD 3 HD 4 (Preliminary Data) HD 5 HD 6 HD 7 Sunburn Percentage of Adults who had a Sunburn in Last 12 Months 2003 Idaho BRFSS 100.0 90.0 80.0 Percent 70.0 60.0 Percent 50.0 40.0 30.0 20.0 10.0 0.0 18-24 25-34 35-44 45-54 (Preliminary Data) 55-64 65+ Synopsis of Melanoma in Idaho • In 2002, there were 263 invasive cases of melanoma and 41 melanoma deaths among Idaho residents. • Melanoma is the 5th most common cancer in Idaho in terms of incidence and 15th most common cause of cancer death. Melanoma Incidence 2002 Geography Health District 1 Health District 2 Health District 3 Health District 4 Health District 5 Health District 6 Health District 7 State of Idaho SEER Whites 2000 SEER All Races 2000 Rate 19.3 12.2 17.4 21.5 14.7 19.0 26.3 20.5 20.9 17.7 Count 40 13 34 68 24 27 38 263 4,366 4,591 Population 184,327 99,799 205,719 363,761 165,289 158,040 164,196 1,341,131 20,536,218 26,723,142 Rates are per 100,000 and age-adjusted to the 2000 U.S. (18 age groups) standard. Top 10 Cancer Incidence - Males 176.9 166.6 Prostate Lung and Bronchus 66.3 79.8 62.5 54.0 Colorectal 22.5 26.9 Melanoma of the Skin 23.4 22.9 Non-Hodgkin Lymphoma Bladder 17.0 Kidney and Renal Pelvis 16.9 16.4 Leukemia 15.2 16.0 SEER 2000 Idaho 2002 37.8 12.8 13.6 Pancreas 15.9 13 Oral Cavity and Pharynx 0 20 40 60 80 100 120 140 Age-Adjusted Rate per 100,000 160 180 200 Top 10 Cancer Incidence -Females 135.1 131.2 Breast 49.8 43.8 Lung and Bronchus Colorectal 33.8 45.9 24.4 20.3 Endometrium 15.4 17.5 SEER 2000 Melanoma of the Skin 14.4 14.7 Idaho 2002 Thyroid 10.8 13.8 Non-Hodgkin Lymphoma 9.4 12.0 Leukemia 16.3 11.6 Ovary 8.3 10.5 Kidney and Renal Pelvis 0 20 40 60 80 100 120 140 Age-Adjusted Rate per 100,000 160 180 200 Incidence NonHispanic White Hispanic Black American Asian or Indian/ Pacific Alaska Islander Native Melanoma of the Skin Incidence, 1990-2001 Males Idaho 9.4 SEER 2.2 Idaho 5.1 SEER 1.8 Idaho SEER 1.4 Idaho 6.8 SEER 3.9 Idaho 21.9 SEER 25.8 0.0 5.0 10.0 15.0 20.0 Age-Adjusted Rate Per 100,000 25.0 30.0 Incidence NonHispanic White Hispanic Black American Asian or Indian/ Pacific Alaska Islander Native Melanoma of the Skin Incidence, 1990-2001 Females Idaho 4.9 SEER 1.8 Idaho 3.8 SEER 1.4 Idaho SEER 0.9 Idaho 9.2 SEER 3.9 Idaho 15.8 SEER 17.2 0.0 5.0 10.0 15.0 20.0 Age-Adjusted Rate Per 100,000 25.0 30.0 Incidence by Age Melanoma of the Skin Incidence, 1998-2002 Age-specific Rates 140 120 SEER White Male Idaho Fem ale 100 SEER White Fem ale 80 60 40 20 Age Group (in years) 85+ 80-84 75-79 70-74 65-69 60-64 55-59 50-54 45-49 40-44 35-39 30-34 25-29 20-24 15-19 10-14 05-09 0 00-04 Rate per 100,000 person-years Idaho Male Incidence 2000 White Males Incidence 2000 White Females Year 20 02 20 00 19 98 19 96 19 94 19 92 19 90 19 88 19 86 19 84 19 82 19 80 19 78 19 76 19 74 19 72 19 70 Age-Adjusted Rates Incidence Trends 25 20 15 Idaho 10 SEER 5 0 Trends • Some experts say the rise in incidence reflects a true increase in the disease, while others contend it is an artifact of more intensive recent surveillance. Some experts suggest that the rise in melanoma incidence may in part reflect longer life expectancy as well as efforts to detect melanoma earlier. • The incidence of thin invasive lesions is increasing faster than that of thick ones, which reflects earlier detection by physicians and greater public awareness of warning signs of skin cancer. • The incidence and mortality rates of melanoma have increased during the past several decades in the United States. Among the reasons for these trends, increased exposure to UV radiation as a result of lifestyle changes is generally recognized as an important factor. SEER Summary Staging 2000 • Cancer staging is the process of describing the extent of the disease or the spread of the cancer from the site of origin. – In situ – noninvasive; basement membrane of epidermis is intact (Clark’s level I) – Localized – papillary/reticular dermis invaded (Clark’s level II-IV) – Regional – subcutaneous tissue invaded (Clark’s level V), satellite nodules <= 2 cm from primary tumor, regional lymph nodes involved – Distant – extension to underlying cartilage, bone, skeletal muscle, metastasis to skin or subcutaneous tissue beyond regional lymph nodes or visceral metastasis Incident Cases by Stage Melanoma Cases by Stage 100% 90% 115 500 142 41 30 16 Percent of Total Cases 80% 70% Unstaged 60% Distant 50% 40% 3,834 420 SEER 2000 Idaho 01-02 30% 20% 10% 0% Regional Localized Melanoma Trends by SEER Summary Stage 25 In situ Idaho Regional Idaho 20 Distant Idaho In situ SEER 15 Localized SEER Regional SEER Distant SEER 10 5 20 02 20 00 19 98 19 96 19 94 19 92 19 90 19 88 19 86 19 84 19 82 19 80 19 78 19 76 19 74 19 72 0 19 70 Age-Adjusted Incidence Rates Localized Idaho Cancer Survival 5-Year Relative Cancer Survival, 1991-2000 Idaho Cases Site Thyroid Prostate Testis Breast Melanoma of the Skin Endometrium Hodgkins Lymphoma Oral Cavity and Pharynx Larynx Cervix Rectum & Rectosigmoid Bladder % Survival Site % Survival 96% Colon 60% 94% Kidney and Renal Pelvis 60% 91% Non Hodgkins Lymphoma 57% 86% Leukemia 46% 85% Ovary 42% 84% Brain 29% 79% Multiple Myeloma 28% 68% Stomach 20% 65% Lung and Bronchus 12% 65% Esophagus 10% 63% Liver 8% 62% Pancreas 4% Melanoma Survival by Stage 100.0% 90.0% Percent Relative Survival 80.0% 70.0% Localized SEER 91-2000 60.0% Localized Idaho 91-2002 Regional SEER 91-2000 50.0% Regional Idaho 91-2002 40.0% Distant SEER 91-2000 Distant Idaho 91-2002 30.0% 20.0% 10.0% 0.0% 1 2 3 4 5 6 Years Survival 7 8 9 10 Melanoma Mortality 2002 Geography Health District 1 Health District 2 Health District 3 Health District 4 Health District 5 Health District 6 Health District 7 State of Idaho US Whites 2000 US All Races 2000 Rate 4.2 3.6 3.0 4.1 1.9 5.0 1.3 3.3 3.0 2.7 Count 8 4 3 11 3 7 2 41 7,245 7,420 Population 184,327 99,799 94,801 363,761 165,289 158,040 164,196 1,341,131 230,019,590 281,421,906 Rates are per 100,000 and age-adjusted to the 2000 U.S. (18 age groups) standard. Leading Causes of Mortality and Melanoma - Males 929.4 All Causes of Death Diseases of Heart All Malignant Cancers Other Cause of Death Accidents and Adverse Effects Cerebrovascular Diseases Lung Cancer COPD Prostate Cancer Diabetes Mellitus Suicide Melanoma of the Skin 1,058.3 252.6 321.6 207.6 249.8 113.5 106.6 62.1 49.4 60.2 62.8 58.1 76.9 57.9 56.1 30.5 30.6 28.1 27.9 27.9 17.7 5.6 3.8 0.0 200.0 400.0 Idaho 2002 US 2000 600.0 800.0 Age-Adjusted Rate per 100,000 1,000.0 1,200.0 Leading Causes of Mortality and Melanoma - Females 677.5 728.6 All Causes of Death Diseases of Heart All Malignant Cancers Other Cause of Death Cerebrovascular Diseases COPD Lung Cancer Accidents and Adverse Effects Alzheimers Breast Cancer Diabetes Mellitus Melanoma of the Skin 162.1 209.9 148.1 167.3 97.5 87.7 58.1 58.7 43.0 37.2 33.0 41.2 31.4 22.0 28.5 19.2 25.2 26.7 23.7 22.9 1.3 1.8 0.0 200.0 Idaho 2002 US 2000 400.0 600.0 800.0 Age-Adjusted Rate per 100,000 1000.0 1200.0 Patterns in Melanoma Mortality • Melanoma mortality in the US reflects the relationship between UV radiation levels in each geographic region, the sunprotection behaviors of each generation of males and females in each age group, the geographic mobility of the population, and risk awareness and early detection. Mortality 1996-2000 White Males Mortality 1996-2000 White Females Year 2 20 02 20 00 19 98 19 96 19 94 19 92 19 90 19 88 19 86 19 84 19 82 19 80 19 78 19 76 19 74 19 72 19 70 Age-Adjusted Rates Mortality Trends 4 3.5 3 2.5 Idaho US 1.5 1 0.5 0 Risks of Developing and Dying from Melanoma Melanoma in Males If your current age is: 30 40 50 60 70 80 If your current age is: 30 40 50 60 70 80 Then your risk of developing melanoma by a particular age is: By age 40 1 in 758 By age 50 1 in 287 1 in 456 By age 60 1 in 135 1 in 162 1 in 244 By age 70 1 in 77 1 in 84 1 in 100 1 in 159 By age 80 1 in 56 1 in 60 1 in 66 1 in 85 1 in 155 Ever 1 in 46 1 in 49 1 in 53 1 in 63 1 in 87 1 in 130* Then your risk of dying from melanoma by a particular age is: By age 40 1 in 5272 By age 50 1 in 1674 1 in 2418 By age 60 1 in 894 1 in 1062 1 in 1840 By age 70 1 in 440 1 in 474 1 in 573 1 in 780 Note: * Risks are not precise - best estimates are shown. By age 80 1 in 285 1 in 297 1 in 329 1 in 376 1 in 616 Ever 1 in 217 1 in 223 1 in 239 1 in 258 1 in 326 1 in 451* Risks of Developing and Dying from Melanoma Melanoma in Females If your current age is: 30 40 50 60 70 80 If your current age is: 30 40 50 60 70 80 Then your risk of developing melanoma by a particular age is: By age 40 1 in 716 By age 50 1 in 296 1 in 501 By age 60 1 in 174 1 in 227 1 in 408 By age 70 1 in 113 1 in 133 1 in 178 1 in 303 By age 80 1 in 84 1 in 94 1 in 113 1 in 150 1 in 263 Ever 1 in 68 1 in 74 1 in 85 1 in 103 1 in 138 1 in 219* Then your risk of dying from melanoma by a particular age is: By age 40 1 in 23414 By age 50 1 in 7968 1 in 11980 By age 60 1 in 2551 1 in 2840 1 in 3657 By age 70 1 in 1517 1 in 1609 1 in 1826 1 in 3498 Note: * Risks are not precise - best estimates are shown. By age 80 1 in 740 1 in 758 1 in 795 1 in 975 1 in 1206 Ever 1 in 497 1 in 504 1 in 516 1 in 577 1 in 616 1 in 948* Prevention of Melanoma • Primary Prevention – Avoiding the disease in the first place • Secondary Prevention – Screening – Early diagnosis and treatment HP 2010 Objectives • Objective 3-9: Increase to 75% the proportion of persons who use at least one of the following protective measures that may reduce the risk of skin cancer: – avoid the sun between 10 a.m. and 4 p.m. – wear sun-protective clothing when exposed to sunlight – use sunscreen with a sun-protection factor (SPF) of 15 or higher – and avoid artificial sources of ultraviolet light • Objective 3-8: Reduce melanoma deaths to 2.5 per 100,000 population Primary Prevention • • Skin cancer is largely preventable when sun protection measures against UV rays are used consistently. Preventing sunburn, especially in childhood, may reduce the lifetime risk for melanoma. Recommendations: – Avoid exposure to the midday sun (from 10 a.m. to 4 p.m.) whenever possible. When your shadow is shorter than you are, remember to protect yourself from the sun. – If you must be outside, wear long sleeves, long pants, and a hat with a wide brim. – Protect yourself from UV radiation that can penetrate light clothing, windshields, and windows. – Protect yourself from UV radiation reflected by sand, water, snow, and ice. Primary Prevention • Only one third of adults reported that they use sunscreen, seek shade, or wear protective clothing when out in the sun. • Adolescents aged 11--18 years were found to routinely practice sun-protective behaviors slightly less than adults (using sunscreen (31%), seeking shade (22%), and wearing long pants (21%). • Among children aged <11 years, sunscreen use (62%) and shade seeking (26.5%) were the most frequently reported sun-protective behaviors. • Young people have moderate to high awareness of skin cancer but are unaware of the connection between severe sunburns and skin cancer; sunburns, although considered painful and embarrassing, are not perceived as a health threat. Findings of the Task Force on Community Preventive Services on Reducing Exposure to Ultraviolet Light • The Task Force recommends two interventions: – educational and policy approaches in primary schools --changing children's covering-up behavior (wearing protective clothing); and – educational and policy approaches in recreational or tourism settings --- changing adults' covering-up behaviors. • The recommended interventions had small to moderate behavior change scores in studies: – In primary schools, the median net relative increase was 25% (interquartile range: 1%--40%, six studies). – In recreational settings, the median net relative increase was 11.2% (interquartile range: 5.1%--12.9%, five studies). Sunscreen • • • Sunscreen's role in preventing skin cancer has been demonstrated to be complex. Using sunscreen has been shown to prevent squamous cell skin cancer. Sunscreens that block both ultraviolet A (UV-A) and ultraviolet B (UV-B) light may be more effective in preventing squamous cell cancer and its precursors than those that block only UV-B light. The evidence for the effect of sunscreen use in preventing melanoma, however, is mixed. – The conflicting results may reflect the fact that sunscreen use is more common among fair-skinned people, who are at higher risk for melanoma; – or, this finding may reflect the fact that sunscreen use could be harmful if it encourages longer stays in the sun without protecting completely against cancer-causing radiation. Secondary Prevention • Self Skin Examinations • Medical Skin Examinations Signs and Symptoms: ABCD Asymmetry Color Border Diameter Cost-Effectiveness of Screening for Malignant Melanoma • Journal of the American Academy of Dermatology. 41(5, Part 1):738-745, November 1999. • The cost-effectiveness ratio for a screening program of adults older than age 20 who were at high risk for skin cancer was about $30,000 per year of life saved. • This is reasonably cost-effective compared with other accepted cancer screening strategies. National Melanoma/Skin Cancer Detection and Prevention Month • May is National Melanoma/Skin Cancer Detection and Prevention Month. This month is dedicated to increasing public awareness of the importance of skin cancer prevention, early detection, and treatment, including basal cell, squamous cell, and melanoma. CDC Resources CDC Resources CDC Resources CDC Resources